Skip to main content

Table 4 Summary of costs collected retrospectively over the 6-month period prior to the follow-up study

From: Long term follow-up of a randomised controlled trial of services for urinary symptoms

   CNP SC CNP v SC
MALE Cost component Mean [SE] (95% CI) Mean [SE] (95% CI) P-value
  Total NHS (excl. P) 91.72 [45.00]
(3.42,180.02)
61.61 [32.36]
(-1.90,125.11)
0.2
  Total Own Borne 2.25 [5.09]
(-7.73,12.23)
3.89 [4.40]
(-4.75,12.53)
0.6
  Total NHS + Own (excl. P) 93.97 [48.17]
(-0.55,188.49)
65.50 [36.43]
(-5.99,136.99)
0.3
FEMALE Cost component Mean [SE] (95% CI) Mean [SE] (95% CI) P-value
  Total NHS 84.96 [28.29]
(29.48,140.44)
60.00 [10.40]
(39.61,80.39)
0.2
  Total Own Borne 29.22 [6.63]
(16.22,42.21)
27.67 [5.86]
(16.18,39.16)
0.6
  Total NHS + Own 114.18 [29.18]
(56.95,171.40)
87.67 [12.36]
(63.44,111.91)
0.2
  1. Updated cost analysis using multiple imputation to deal with missing data (covariates used to impute: 4 urinary symptoms (urgency, leakage, nocturia and frequency), number of symptoms, age, body mass index & EQ-5D).